N-linked glycoside/glucuronide conjugates of retinoids: Acitretin

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 23, 1997, Pages 3033-3038

  Balakrishnan, V ^a   Gilbert, N E ^a   Brueggemeier, R W ^a   Curley Jr , R W ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACITRETIN DERIVATIVE; ETRETIN; GLYCOSIDE; N (4 HYDROXYPHENYL)RETINAMIDE O GLUCURONIDE; RETINOID; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN MCF 7; CHIRALITY; CHROMATOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; DRUG CONJUGATION; DRUG PURIFICATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; STEREOCHEMISTRY;

EID: 0030696976     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)10140-8     Document Type: Article

References (18)

1. Hong, W. K.; Itri, L. M. In The Retinoids: Biology, Chemistry, and Medicine, 2nd Ed.; Sporn, M. B.; Roberts, A. B.; Goodman, D. S., Eds.; Wiley:New York, 1994; pp. 597-630.
2. Zile, M. H.; Cullum, M. E.; Simpson, R. U.; Barua, A. B.; Swartz, D. A. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 2208.
3. Dawson, M. I.; Hobbs, P. D. Carbohydr. Res. 1980, 85, 121.
4. Bhatnagar, R.; Abou-Issa, H.; Curley, R. W., Jr.; Koolemans-Beynan, A.; Moeschberger, M. L.; Webb, T. E. Biochem. Pharmacol. 1991, 41, 1471.
5. Abou-Issa, H.; Curley, R. W., Jr.; Panigot, M. J.; Wilcox, K. A.; Webb, T. E. Anticancer Res. 1993, 13, 1431.
6. Ubels, J. L.; Dennis, M. H.; Mitchell, J. H.; Wiley, L. A.; Curley, R. W., Jr. Curr. Eye Res. 1995, 14, 1115.
7. Curley, R. W., Jr.; Robarge, M. J. Curr. Med. Chem. 1996, 3, 325.
8. Curley, R. W., Jr.; Abou-Issa, H.; Panigot, M. J.; Repa, J. J.; Clagett-Dame, M.; Alshafie, G. Anticancer Res. 1996, 16, 757.
9. Robarge, M. J.; Curley, R. W. Jr. "Abstracts of Papers", 210th National Meeting of the American Chemical Society, Chicago, IL, August 1995; American Chemical Society: Washington, D.C., 1995; MEDI 204.
10. Robarge, M. J.; Repa, J. J.; Hanson, K. K.; Seth, S.; Clagett-Dame, M.; Abou-Issa, H.; Curley, R. W., Jr. Bioorg. Med. Chem. Lett. 1994, 4, 2117.
11. Orfanos, C. E.; Zouboulis, C. C.; Almond-Roesler, B.; Geilen, C. C. Drugs 1997, 53, 358.
12. Vane, F. M.; Bugge, C. J. L.; Rodriguez, L. C. Drug Metab. Disp. 1989, 17, 280.
13. R = 122 min; FABMS, m/e (relative intensity) 510 (M+Na, 52.8), 488 (M+H, 39.1), 217 (100).
14. R = 10 min; FABMS m/e (relative intensity) 524 (M+Na, 22.3), 502 (M+1, 25.7), 163 (100).
15. Mangelsdorf, D. J.; Umesono, K.; Evans, R. M. In The Retinoids: Biology, Chemistry, and Medicine, 2nd Ed.; Sporn, M. B.; Roberts, A. B.; Goodman, D. S., Eds.; Wiley:New York, 1994; pp 319-349.
16. Gilbert, N. E.; O'Reilly, J. E.; Chang, C. J.; Lin, Y. C.; Brueggemeier, R. W. Life Sciences 1995, 57, 61.
17. Bollag, W. Chemotherapy 1975, 21, 236.
18. Pawson, B. A.; Chan, K.-K.; DeNoble, J.; Han, R.-J. L.; Piermattie, V.; Specian, A. C.; Srisethnil, S. J. Med. Chem. 1979, 22, 1059.